These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 2800054

  • 1. Comparative study of the circadian rhythmicity in the urinary concentration of glycosaminoglycans in patients of calcium oxalate nephrolithiasis and in healthy adults.
    Sidhu H, Thind SK, Nath R, Vaidyanathan S, Hemal AK, Mandal AK, Krishan K.
    Urol Int; 1989; 44(4):218-21. PubMed ID: 2800054
    [Abstract] [Full Text] [Related]

  • 2. Effect of diclofenac-Na on 24-hour urinary excretion of creatinine, calcium, uric acid and glycosaminoglycans in adult patients with recurrent calcium oxalate nephrolithiasis.
    Hemal AK, Sidhu H, Thind SK, Nath R, Vaidyanathan S.
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):44-6. PubMed ID: 2744906
    [Abstract] [Full Text] [Related]

  • 3. Comparative study of 24-hour urinary excretion of glycosaminoglycans by renal stone formers and healthy adults.
    Sidhu H, Hemal AK, Thind SK, Nath R, Vaidyanathan S.
    Eur Urol; 1989 Jan; 16(1):45-7. PubMed ID: 2714317
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Significance of glycosaminoglycans for the formation of calcium oxalate stones.
    Hesse A, Wuzel H, Vahlensieck W.
    Am J Kidney Dis; 1991 Apr; 17(4):414-9. PubMed ID: 2008909
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Urinary glycosaminoglycans as risk factors for uric acid nephrolithiasis: case control study in a Sardinian genetic isolate.
    Ombra MN, Casula S, Biino G, Maestrale G, Cardia F, Melis P, Pirastu M.
    Urology; 2003 Sep; 62(3):416-20. PubMed ID: 12946738
    [Abstract] [Full Text] [Related]

  • 11. Urinary glycosaminoglycans and glycoproteins in a calcium oxalate crystallization system.
    Poon NW, Gohel MD.
    Carbohydr Res; 2012 Jan 10; 347(1):64-8. PubMed ID: 22119438
    [Abstract] [Full Text] [Related]

  • 12. Correction of erythrocyte abnormalities in idiopathic calcium-oxalate nephrolithiasis and reduction of urinary oxalate by oral glycosaminoglycans.
    Baggio B, Gambaro G, Marchini F, Marzaro G, Williams HE, Borsatti A.
    Lancet; 1991 Aug 17; 338(8764):403-5. PubMed ID: 1678082
    [Abstract] [Full Text] [Related]

  • 13. Urinary glycosaminoglycans in normal subjects and patients with stones.
    Hwang TI, Preminger GM, Poindexter J, Pak CY.
    J Urol; 1988 May 17; 139(5):995-7. PubMed ID: 3361677
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K, Mayne K, Doyle IR, Ryall RL.
    Scanning Microsc; 1994 May 17; 8(3):523-30. PubMed ID: 7747154
    [Abstract] [Full Text] [Related]

  • 18. Alterations in circadian rhythmicity in calcium oxalate renal stone formers.
    Touitou Y, Touitou C, Charransol G, Reinberg A, Thomas J, Bogdan A, Barthelemy C, Desgrez P.
    Int J Chronobiol; 1983 May 17; 8(3):175-92. PubMed ID: 6862698
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.